Clinical Trials Browser

Phase 2 × Recurrence × ixazomib × Clear all

NCT03683277 2025-02-19

IFM2014-01

Phase 2 Terminated

Multiple Myeloma, Recurrence, Genetic Diseases, Inborn

NCT02499081 2021-06-11

UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment

Phase 2 Completed

20 enrolled 9 charts

Multiple Myeloma, Recurrence

NCT02578121 2017-01-23

UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination

Phase 2 Withdrawn

Multiple Myeloma, Recurrence